STOCK TITAN

AMBEV S.A. (ABEV) SEC Filings, Jul-Oct 2025

ABEV NYSE

Ambev S.A. filings document the reporting cycle of a Brazilian foreign private issuer with NYSE ADRs and B3-listed common shares. Form 20-F reports cover audited financial statements and annual business disclosure, while Form 6-K submissions furnish interim consolidated financial statements, quarterly operating results and current reports under Exchange Act rules for foreign issuers.

The filing record also covers beverage segment performance in Brazil Beer, Brazil NAB, Latin America South, Central America and the Caribbean, and Canada; capital allocation through interest on capital; treasury share activity; management and related-person securities transactions under Brazilian CVM rules; shareholder-meeting voting maps; board resolutions; committee matters; compensation; and other governance disclosures.

Rhea-AI Summary

Ambev S.A. reported stronger 9M 2025 results. Net sales reached R$63.43 billion, up modestly year over year, while net income rose to R$11.46 billion as operating profit improved and the effective tax rate eased. Basic EPS was R$0.7141. Q3 showed softer top-line trends, with net sales of R$20.85 billion and net income of R$4.86 billion.

Results include an exceptional gain of R$884 million from the partial disposal and deconsolidation of SLU Beverages, recorded within non-recurring items. Operating cash flow was R$11.20 billion; after investing outflows and significant shareholder distributions, cash and cash equivalents were R$18.31 billion at period end. The company paid three dividends in 2025 totaling R$5.999 billion, including R$0.1283 per share approved on July 30 and paid on October 6. Currency translation effects drove a comprehensive loss despite positive net income.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.50%
Tags
current report
-
Rhea-AI Summary

Ambev S.A. filed an update on share and derivative positions held by its board, management, and fiscal council for the period from September 1 to 30, 2025, under Brazilian Instruction 358.

The board of directors group held 12,107,569 common shares and 468,040 ADRs, with no transactions during the month and the same final balances. The fiscal council held 2,500 common shares, also unchanged over the period.

Within the management group, the initial balance was 3,754,620 common shares and 19,790 ADRs. During September, there was a sale of 5,000 common shares through Corretora Itaú at R$ 12.50 per share, totaling R$ 62,500. There was also an “Election” entry of 33,436 common shares at zero price. The management group closed the month with 3,783,056 common shares and 19,790 ADRs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
current report
-
Rhea-AI Summary

Ambev S.A. filed a report detailing its own transactions in company securities for September 2025 under Brazilian CVM Instruction 358. The company used treasury shares to fulfill a delivery of restricted shares, moving 146,923 common shares out of treasury at a reference price of R$ 12,30 per share, for a stated volume of R$ 1,807,152.90. As a result, Ambev’s treasury position in common shares changed from 169,352,327 at the beginning of the month to 169,205,404 at month-end, with no ADRs held in treasury.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
current report
Rhea-AI Summary

Ambev reported an individual disclosure under Article 11 of CVM Instruction No. 358/2002 showing a single securities movement in July 2025. The company delivered 52,524 restricted common shares from treasury at a price of R$13.38 per share, producing a reported cash volume of R$702,771.12.

The filing shows the treasury (outstanding shares in treasury) fell from 169,428,968 to 169,376,444. No ADR holdings are reported. The report is signed by the company’s Chief Financial and Investor Relations Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
current report
-
Rhea-AI Summary

Ambev S.A. disclosed consolidated related‑party transactions covering July 1–31, 2025 under Article 11 of CVM Instruction 358/2002. The Board of Directors and Fiscal Council reported no changes: the Board holds 12,107,569 common shares and 468,040 ADRs, and the Fiscal Council holds 2,500 common shares.

Management began the period with 4,314,194 common shares and 19,790 ADRs. On day 8 management sold 98,200 shares at R$13.38 (R$1,313,916.00) and 63 shares at R$13.39 (R$843.57), leaving a final management position of 4,215,931 common shares and 19,790 ADRs. Each ADR is reported as equivalent to one share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
current report
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
current report
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
current report

FAQ

How many AMBEV S.A. (ABEV) SEC filings are available on StockTitan?

StockTitan tracks 143 SEC filings for AMBEV S.A. (ABEV), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMBEV S.A. (ABEV)?

The most recent SEC filing for AMBEV S.A. (ABEV) was filed on October 30, 2025.